Pharmacogenomics Market Accretes Dramatically With A Whooping CAGR ~5.8 %, Global Share, Size by Year 2023; Confirms MRFR

Global Pharmacogenomics Market – Overview

The pharmacogenomics market is growing at an incremental pace of development on the global stage due to the large number of advantages associated to personalized therapy. Market Research Future, a firm which specializes in market reports related to the healthcare sector among others, recently forecasted in its report on Global Pharmacogenomics Market Research Report- Forecast to 2023 that the market will demonstrate an exceptional CAGR ~5.8 % while achieving million dollar growth readily in the forecast period.

The key players profiled in pharmacogenomics market report includes Myriad Genetics, Inc. (U.S.), 23andMe, Inc. (U.S.), Pathway Genomics (U.S.), GeneTech (U.S.), GeneDx. (U.S.), Future Science Group (U.S.), Teva Pharmaceutical Industries Ltd. (Israel), Assurex Health, Inc. (U.S.), OneOme (U.S.) and others.

Avail Sample Research Report at https://www.marketresearchfuture.com/sample_request/1177

Latest Industry Updates

Nov 2017: Myriad Genetics, Inc., announced positive results from a double-blind, multi-center, randomized controlled trial assessing the impact of the GeneSight Psychotropic test (GeneSight) on psychiatric treatment response in 1,200 patients with major depressive disorder. GeneSight is one of the leading pharmacogenomics test to help guide medication selection for mental health disorders.

June 2016: OneOme announced about key business milestones in advance of launching its RightMed test. RightMed test is a cost-effective, comprehensive, personalized pharmacogenomics product which analyses 22 genes which provided at the point of care. The OneOme platform was co-developed and exclusively licensed from Mayo Clinic to bring pharmacogenomics into routine clinical care. OneOme’s RightMed test is currently in use by Mayo Clinic Center for individualized medicine. The test helps providers easily make personalized treatment decisions across more than 300 medications for more than 20 medical indications.

Pharmacogenomics plays an important role in drug discovery and development. Pharmacogenomics refers to the effects of genetic polymorphism and genomic variants on drug response, its information can help in selection of the optimal drug, dose, treatment process, and avoid adverse drug reactions. As adverse drug reactions have been reported as one of the leading causes of death among hospitalized patients. Adverse drug reactions are also referred as the factor behind loss of confidence in the healthcare system and the diminishing satisfaction of both patients and health professionals.

Pharmacogenomics approach aids pharmaceutical companies to design drugs that satisfies the requirements of particular genetic sub-groups of the general population. The main interest of pharmacogenomics is to identify patients for whom drug efficacy can be predicted, and to reduce risk of adverse drugs effects. The main and important pharmacogenomics approaches is to prescribe drugs on the basis of their patients’ genetic profiles which is termed as ‘personalized medicine.

Brows Full Detailed Report at https://www.marketresearchfuture.com/reports/pharmacogenomics-market-1177

Global Pharmacogenomics Market - Regional Analysis

The global pharmacogenomics market is segmented into Americas, Europe, Asia Pacific and the Middle East & Africa. Global pharmacogenomics market is highly dominated by North America and Europe due to majority of pharmaceutical companies engaged in research & development activities, increasing awareness about side effects of a drug among the people, production of next generation PCR technology and microarray system which drive the growth of this market.

APAC is fastest growing region due to the presence of a huge patient population, continuously developing economies like India and China and presence of huge opportunities drives the market growth. For instance, According to the Indian Brand Equity Foundation in 2016, the Indian biotech industry is estimated to reach USD 100 billion by 2025 from USD 7.0 billion in 2015.

Intended Audience

Pharmaceutical companies
Biotechnological institutes
Government and Private Laboratories
Research and Development (R&D) Companies
Medical Research Laboratories
Market Research and Consulting Service Providers

Inquire for Discount at https://www.marketresearchfuture.com/check-discount/1177

About Market Research Future: MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar, Pune

+1 646 845 9312

Email: sales@marketresearchfuture.com

This release was published on openPR.